Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) Final LCD - Effective October 26, 2025

Date Posted: September 11, 2025

This Local Coverage Determination (LCD) has completed the Open Public Meeting and Contractor Advisory Committee (CAC) comment period and is now finalized under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories). Responses to comments received may be found as a link at the bottom of the final LCD.

Medicare Coverage Database (MCD) Number/Contractor Determination Number: L40050

LCD Title: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)

Effective Date: October 26, 2025

Summary of LCD: This Local Coverage Determination (LCD) has been developed to create a policy consistent with current evidence and covers allergen immunotherapy. This LCD outlines limited coverage for this service with specific details under Coverage Indications, Limitations and/or Medical Necessity.

Visit the Proposed LCDs webpage to access this LCD.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )